SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015German Hepatitis C Resistance Registry - Christophe Sarrazin, MDView Slideset
SCStéphane ChevaliezPharmD, PhDSlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Resistance Case and Preventing Resistance - Stéphane Chevaliez, PharmD, PhDView Slideset
MBMaria ButiMD, PhDSlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Patients in Spain - Maria Buti, MD, PhDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Patients in Holland - Rob de Knegt, MD, PhDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Patients in Germany - Heiner Wedemeyer, MDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Patients in Poland - Robert Flisiak, MD, PhDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Patients in the US - Fred Poordad, MDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 201511_ZeuzemView Slideset
MNMark NelsonMD, MBBS, FRCPSlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Viral Co‐Infection - Mark Nelson, MDView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 201510_SarrazinView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 201509_ArendsView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 201508_sarrazinView Slideset